Search results
Results from the Tech24 Deals Content Network
Since then, Humana has grown into a Medicare Advantage powerhouse, boasting 18% of the enrollment in MA plans in 2023 — second only to UnitedHealthcare's 29% — according to KFF.
November 30, 2023 at 4:20 PM. WASHINGTON (Reuters) - U.S. health insurers Cigna and Humana are in talks to merge, a potential deal likely to face aggressive scrutiny from the U.S. Justice ...
UnitedHealth Group Incorporated. UnitedHealth Group Incorporated is an American multinational health insurance and services company based in Minnetonka, Minnesota. Selling insurance products under UnitedHealthcare, and health care services and care delivery aided by technology and data under Optum, it is the world's eleventh-largest company by ...
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. In 2023, the company ranked 42 on the Fortune 500 list, [ 2] which made it the highest ranked (by revenues) company based in Kentucky. It is the fourth largest health insurance provider in the U.S. [ 3]
Under the latest extension terms, UnitedHealth's Optum unit, which offers healthcare data analytics services, will pay a $650 million fee to Change if the deal is not completed due to the court's ...
On April 16, 2010, Cigna announced an alliance with Humana group to offer a streamlined Medicare Advantage offering through employer clients for retirees. [54] In November 2023, Reuters reported that Cigna and Humana were in talk to merge, in a deal totalling $60 billion. [55] In December 2023, The Wall Street Journal reported that merger talks ...
US$ 226.6 billion (2023) [ 1] Parent. UnitedHealth Group. Website. www .optum .com /en /. Optum, Inc. is an American healthcare company that provides technology services, pharmacy care services (including a pharmacy benefit manager) and various direct healthcare services. Optum was formed as a subsidiary of UnitedHealth Group in 2011 by merging ...
The health insurer expects 2024 adjusted profit growth to be at the lower end of its long-term target range of 11% to 15%, assuming same level of utilization continues into next year, Humana's ...